No Data
Zylox-Tonbridge Medical Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Guichuang Tongqiao released its performance for the year 2024: it achieved annual profitability for the first time, with Net income exceeding 0.1 billion yuan.
On March 20, Guichuang Tongqiao Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Guichuang Tongqiao" or "the Company") released its performance announcement for the year 2024. In 2024, Guichuang Tongqiao achieved revenue of 0.78 billion yuan, a year-on-year increase of 48.3%; net income exceeded 0.1 billion yuan, marking the first time the company achieved profitability for the whole year. In the face of a complex and changing market environment, Guichuang Tongqiao benefits from the economies of scale brought by continuous revenue growth, entering a new phase of scaled profitability. This fully demonstrates the company's strong capabilities in the development of comprehensive product solutions, high-quality product supply, and efficient operation. Looking ahead, Guichuang Tongqiao...
Express News | Zylox-Tonbridge Medical Technology FY Adjusted Net Income RMB 124 Million
Express News | Zylox-Tonbridge Medical Technology FY Gross Profit RMB 559.9 Million
Express News | Zylox-Tonbridge Medical Technology FY Revenue RMB 782.5 Million
Express News | Zylox-Tonbridge Medical Technology FY Gross Margin 71.6%
Press Release: Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
